SynthesisThoracic cancer2021

Anti-PD1 versus anti-PD-L1 immunotherapy in first-line therapy for advanced non-small cell lung cancer: A systematic review and meta-analysis.

Angelo Borsarelli Carvalho Brito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.